EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Duffy antigen: A narrative review of testing, epidemiology, neutrophil counts and clinical consequences

Stephen P Hibbs iD, Jennifer Jones iD, Andrew Hantel iD, Lauren E Merz iD

British Journal of Haematology · 2025-09 · 207 (3) · 737-749

DOI: 10.1111/bjh.20258 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 21.07.2025. Verfasst von Stephen P Hibbs und 3 weiteren Autor:innen. Beteiligte Einrichtung: Wolfson Institute for Population Health, Queen Mary University of London, London, UK. Hauptthemen laut MEDLINE: Duffy Blood-Group System, Neutrophils, Malaria, Vivax, Receptors, Cell Surface. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 89 Literaturangaben. Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The null variant of the Duffy antigen is a non‐pathological mutation that is partially protective against Plasmodium vivax and results in a lower absolute neutrophil count (ANC) in peripheral blood without increasing the risk of infection. Healthcare practices, clinical trials eligibility and medication dosing are often influenced by the definition of neutropenia. In many regions, however, neutropenia has been defined by the ANC distribution of Duffy‐positive individuals, which may be unsuitable for decision‐making in Duffy null individuals. This review describes the association between Duffy status, Plasmodium vivax exposure, racial or ethnic groupings and ANC. We outline biological and iatrogenic associations between Duffy antigen status and health outcomes and recommend changes to healthcare practices required to ensure equity for Duffy null individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Duffy Blood-Group SystemNeutrophilsMalaria, VivaxReceptors, Cell SurfacePlasmodium vivaxHumansLeukocyte CountNeutropenia

Stichwörter der Autor:innen

blood groupschronic neutropeniaclinical haematologygeneral haematologyneutropeniared cell antigens

Substanzen

Duffy Blood-Group SystemACKR1 protein, humanReceptors, Cell Surface

Autor:innen und Institutionen

  • Wolfson Institute for Population Health, Queen Mary University of London, London, UK.
  • Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Center for Bioethics, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Stephen P Hibbs, Jennifer Jones, Andrew Hantel, Lauren E Merz

Förderung

  • Wellcome Trust

Zitieren

APA

Hibbs, S. P., Jones, J., Hantel, A., & Merz, L. E. (2025). The Duffy antigen: A narrative review of testing, epidemiology, neutrophil counts and clinical consequences. British Journal of Haematology, 207(3), 737-749. https://doi.org/10.1111/bjh.20258

Vancouver

Hibbs SP, Jones J, Hantel A, Merz LE. The Duffy antigen: A narrative review of testing, epidemiology, neutrophil counts and clinical consequences. British Journal of Haematology. 2025;207(3):737-749. doi:10.1111/bjh.20258

BibTeX
@article{Hibbs2025,
  author = {Hibbs, Stephen P and Jones, Jennifer and Hantel, Andrew and Merz, Lauren E},
  title = {The Duffy antigen: A narrative review of testing, epidemiology, neutrophil counts and clinical consequences},
  journal = {British Journal of Haematology},
  year = {2025},
  volume = {207},
  number = {3},
  pages = {737--749},
  doi = {10.1111/bjh.20258}
}
Kostenlos starten →